yingweiwo
  1. Home
  2. Products
  3. Signaling Pathways
  4. New Products
  5. NEW3
  6. New11

New11

New11

New11 related products

Structure Cat No. Product Name CAS No. Product Description
(E/Z)-Zotiraciclib citrate-TG-02 citrate; SB-1317 citrate V50422 (E/Z)-Zotiraciclib citrate-TG-02 citrate; SB-1317 citrate 1204918-73-9 (E/Z)-Zotiraciclib citrate (TG02 citrate; SB1317 citrate is a novel and potent CDK2, JAK2, and FLT3 inhibitorwith the potential for the treatment of cancer.
(Rac)-Vepdegestrant [(Rac)-ARV-471] V41444 (Rac)-Vepdegestrant 2229711-08-2 (Rac)-Vepdegestrant (ARV-471 racemate; ARV471) is a first-in-class, selective and orally bioavailable PROTAC-based Estrogen Receptor (AR) degrader.
Bay-3827 V41400 Bay-3827 2377576-35-5 BAY-3827 is a potent and specific AMPK inhibitor (antagonist) with IC50s of 1.4 nM (10 µM ATP) and 15 nM (2 mM ATP).
BIIB068 V41447 BIIB068 1798787-27-5 BIIB068 (BIIB-068) is a novelreversible and orally bioavailable BTK inhibitor with the potential to be used for autoimmune diseases such as systemic lupus erythematosus (SLE).
BMVC-8C3O V37648 BMVC-8C3O 1301708-12-2 BMVC-8C3O is a novel ligand of DNA G-quadruplexe (G4) that can induce topological conversion of non-parallel to parallel forms in human telomeric DNA G4s.
C-021 (CCR4 antagonist) V41389 C-021 (CCR4 antagonist) 864289-85-0 C021 (C-021; CCR4 antagonist) is a novel and potent CCR4 antagonist with anti-inflammatory activity.
CCR6 antagonist 1 V42163 CCR6 antagonist 1 588674-64-0 CCR6 antagonist 1 is a CCR6 antagonist with the potential tobe used in autoimmune diseases, e.
Compound 6q V41588 Compound 6q Compound 6q is a novel and potent steroidal anti-inflammatory agent that has the potential to be used in the treatment of IBD (inflammatory bowel diseases).
DDO-7263 V49209 DDO-7263 2254004-96-9 DDO-7263 is a 1,2,4-Oxadiazole analogue and a potent Nrf2-ARE activator.
G-谷氨酸-半胱 V41419 gamma-Glu-Cys 636-58-8 Gamma-glutamylcysteine (amma-Glu-Cys) is a substrate for biosynthesis of L-glutathione by glutathione synthetase.
GRK6-IN-1 V50576 GRK6-IN-1 2677786-61-5 GRK6-IN-1 (compound 18) is a potent inhibitor of G protein-coupled receptor kinase 6 (GRK6) with IC50 of 120 nM.
GS-441524 HCl V37640 GS-441524 HCl 2378280-82-9 GS-441524 is an active metabolite of Remdesivir (GS-5734;Veklury) which is an FDA approved drug for treating the2019-nCoV (COVID-19 pandemic, CoronaVirus)infections.
MLN-3126 V44412 MLN-3126 628300-71-0 MLN3126 is an orally bioactive and potent CCR9 antagonist.
Mtb-ATP合成酶-IN-1 V47181 Mtb ATP synthase-IN-1 2642394-38-3 Mtb ATP synthase-IN-1 (compound 6ab) is a potent inhibitor of Mycobacterium tuberculosis (TB) (Mtb) ATP synthesis, with MIC of Mtb of 0.452 ~ 0.499 μg/mL.
MYLS22 V41464 MYLS22 306959-01-3 MYLS22 is a selective inhibitor of optic atrophy 1 (OPA1).
NS-3-008 HCl V37656 NS-3-008 HCl 1172854-54-4 NS-3-008 is a novel and orally bioactive transcriptional inhibitor of G0/G1 switch 2 (G0s2).
P2Y2R/GPR17 antagonist 1 V47326 P2Y2R/GPR17 antagonist 1 2395016-49-4 P2Y2R/GPR17 antagonist 1 (Compound 14m) is a dual P2Y2R and GPR17 antagonist (inhibitor) with IC50s of 3.17 µM and 1.67 µM for P2Y2R and GPR17, respectively.
SHMT-IN-2 V44337 SHMT-IN-2 2102681-49-0 SHMT-IN-2 is an inhibitor of human SHMT1/2 which is aserine hydroxymethyltransferase (SHMT).
SRI-37240 V42907 SRI-37240 883956-47-6 SRI-37240 is a potent inhibitor of premature termination codons (PTCs).
VLX600 HCl V37651 VLX600 HCl 1622945-04-3 VLX600 is a novel Iron Chelator Targeting Both Proliferating and Quiescent Cancer Cells.
Contact Us
Tel: 1-708-310-1919 Fax: 1-708-557-7486 Email: sales@invivochem.com Frequently Asked Questions
Subscribe to our E-newsletter
Name
E-mail

Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved

linkedin facebook
Contact Us
Home Product Cart Member